Conspectus
Continued,
rapid development of antimicrobial resistance has become
worldwide health crisis and a burden on the global economy. Decisive
and comprehensive action is required to slow down the spread of antibiotic
resistance, including increased investment in antibiotic discovery,
sustainable policies that provide returns on investment for newly
launched antibiotics, and public education to reduce the overusage
of antibiotics, especially in livestock and agriculture. Without significant
changes in the current antibiotic pipeline, we are in danger of entering
a post-antibiotic era.
In this Account, we summarize our recent
efforts to develop next-generation
streptogramin and lankacidin antibiotics that overcome bacterial resistance
by means of modular chemical synthesis. First, we describe our highly
modular, scalable route to four natural group A streptogramins antibiotics
in 6–8 steps from seven simple chemical building blocks. We
next describe the application of this route to the synthesis of a
novel library of streptogramin antibiotics informed by in vitro and
in vivo biological evaluation and high-resolution cryo-electron microscopy.
One lead compound showed excellent inhibitory activity in vitro and
in vivo against a longstanding streptogramin-resistance mechanism,
virginiamycin acetyltransferase. Our results demonstrate that the
combination of rational design and modular chemical synthesis can
revitalize classes of antibiotics that are limited by naturally arising
resistance mechanisms.
Second, we recount our modular approaches
toward lankacidin antibiotics.
Lankacidins are a group of polyketide natural products with activity
against several strains of Gram-positive bacteria but have not been
deployed as therapeutics due to their chemical instability. We describe
a route to several diastereomers of 2,18-seco-lankacidinol
B in a linear sequence of ≤8 steps from simple building blocks,
resulting in a revision of the C4 stereochemistry. We next detail
our modular synthesis of several diastereoisomers of iso-lankacidinol that resulted in the structural reassignment of this
natural product. These structural revisions raise interesting questions
about the biosynthetic origin of lankacidins, all of which possessed
uniform stereochemistry prior to these findings. Finally, we summarize
the ability of several iso- and seco-lankacidins to inhibit the growth of bacteria and to inhibit translation
in vitro, providing important insights into structure–function
relationships for the class.